KRAS and colorectal carcinoma: Radiomic signatures that can predict the V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation in CRC have been studied, where it was interesting to note that radiomic signal based on CT was superior to FDG PET for that purpose (28).